BR0111581A - Processos para a preparação de pirazolopirimidinonas - Google Patents

Processos para a preparação de pirazolopirimidinonas

Info

Publication number
BR0111581A
BR0111581A BR0111581-2A BR0111581A BR0111581A BR 0111581 A BR0111581 A BR 0111581A BR 0111581 A BR0111581 A BR 0111581A BR 0111581 A BR0111581 A BR 0111581A
Authority
BR
Brazil
Prior art keywords
processes
preparation
pyrazolopyrimidinones
compound
formula
Prior art date
Application number
BR0111581-2A
Other languages
English (en)
Inventor
Peter James Dunn
Catherine Dunne
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0111581(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0015472A external-priority patent/GB0015472D0/en
Priority claimed from GB0105857A external-priority patent/GB0105857D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BR0111581A publication Critical patent/BR0111581A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PROCESSOS PARA A PREPARAçãO DE PIRAZOLOPIRIMIDINONAS". é fornecido um processo para a produção de um composto de fórmula geral I: em que A, A^ 1^, R^ 2^, R^ 3^ e R^ 4^ têm os significado dados na descrição, processo que compreende a reação de um composto de fórmula (II), em que R^ x^ é um grupo que pode ser substituído por um aminopirazol, com um composto de fórmula geral (III)
BR0111581-2A 2000-06-22 2001-06-11 Processos para a preparação de pirazolopirimidinonas BR0111581A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0015472A GB0015472D0 (en) 2000-06-22 2000-06-22 Novel process for the preparation of pyrazolopyrimidinones
GB0105857A GB0105857D0 (en) 2001-03-09 2001-03-09 Novel process for the preparation of pyrazolopyrimidinones
PCT/IB2001/001050 WO2001098284A1 (en) 2000-06-22 2001-06-11 Process for the preparation of pyrazolopyrimidinones

Publications (1)

Publication Number Publication Date
BR0111581A true BR0111581A (pt) 2003-03-25

Family

ID=26244540

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111581-2A BR0111581A (pt) 2000-06-22 2001-06-11 Processos para a preparação de pirazolopirimidinonas

Country Status (29)

Country Link
EP (1) EP1292586B1 (pt)
JP (1) JP2004501142A (pt)
KR (1) KR100525698B1 (pt)
CN (1) CN100338047C (pt)
AP (1) AP2001002194A0 (pt)
AR (1) AR028740A1 (pt)
AT (1) ATE272626T1 (pt)
AU (2) AU2001262597B2 (pt)
BR (1) BR0111581A (pt)
CA (1) CA2411961C (pt)
CZ (1) CZ20024176A3 (pt)
DE (1) DE60104691T2 (pt)
DK (1) DK1292586T3 (pt)
DO (1) DOP2001000190A (pt)
ES (1) ES2223863T3 (pt)
HK (1) HK1054926A1 (pt)
HU (1) HUP0301183A3 (pt)
IL (1) IL153532A0 (pt)
MX (1) MXPA02012884A (pt)
MY (1) MY124903A (pt)
PA (1) PA8519801A1 (pt)
PE (1) PE20020105A1 (pt)
PL (1) PL359651A1 (pt)
PT (1) PT1292586E (pt)
SV (1) SV2002000503A (pt)
TN (1) TNSN01093A1 (pt)
TR (1) TR200401983T4 (pt)
WO (1) WO2001098284A1 (pt)
YU (1) YU93902A (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310144B1 (es) * 2007-06-15 2010-01-12 Galenicum Health, S.L. Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
BRPI0722222A2 (pt) * 2007-12-28 2015-06-16 Topharman Shangai Co Ltd N-{1-[3-(2-etóxi-5-(4-etilpiperazinil)sulfonilfenil)-4,5-di hidro-5-oxo-1,2,4-triazina-6-il]etil}butiramida, seu método de preparo e seu uso
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
CA2770471A1 (en) 2009-08-07 2011-02-10 Ranbaxy Laboratories Limited Processes for the preparation of vardenafil
WO2011088192A1 (en) 2010-01-13 2011-07-21 Tempero Pharmaceuticals, Inc. Compounds and methods
MX2010006227A (es) 2010-06-07 2011-12-14 World Trade Imp Exp Wtie Ag Nuevos derivados 1,4-diazepanos, inhibidores de pde-5.
FR2970967B1 (fr) 2011-01-27 2013-02-15 Pf Medicament Derives de type azaindazole ou diazaindazole comme medicament
EP2689778A1 (en) 2012-07-27 2014-01-29 Pierre Fabre Medicament Derivatives of azaindoles or diazaindoles for treating pain
EP2689779A1 (en) 2012-07-27 2014-01-29 Pierre Fabre Medicament Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing trk
EP3529246B1 (en) * 2016-10-24 2023-10-18 FMC Corporation Oxadiazoles having fungicidal activity
KR20210098949A (ko) * 2018-10-01 2021-08-11 피아이 인더스트리스 엘티디. 새로운 옥사디아졸

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822238D0 (en) * 1998-10-12 1998-12-09 Pfizer Ltd Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
EP1002798A1 (en) * 1998-11-20 2000-05-24 Orchid Chemicals & Pharmaceuticals Ltd. An improved process for preparing a therapeutically active pyrazolopyrimidinone derivative

Also Published As

Publication number Publication date
HK1054926A1 (en) 2003-12-19
CZ20024176A3 (cs) 2004-01-14
PA8519801A1 (es) 2002-04-25
PE20020105A1 (es) 2002-02-21
HUP0301183A2 (hu) 2003-08-28
CA2411961C (en) 2007-02-06
CN100338047C (zh) 2007-09-19
AP2001002194A0 (en) 2002-12-21
TNSN01093A1 (fr) 2005-11-10
HUP0301183A3 (en) 2006-02-28
AU6259701A (en) 2002-01-02
ATE272626T1 (de) 2004-08-15
MY124903A (en) 2006-07-31
DE60104691D1 (de) 2004-09-09
AU2001262597B2 (en) 2005-10-20
EP1292586A1 (en) 2003-03-19
DK1292586T3 (da) 2004-08-30
ES2223863T3 (es) 2005-03-01
AR028740A1 (es) 2003-05-21
KR20030031912A (ko) 2003-04-23
PL359651A1 (en) 2004-08-23
CN1437589A (zh) 2003-08-20
MXPA02012884A (es) 2003-05-14
PT1292586E (pt) 2004-11-30
IL153532A0 (en) 2003-07-06
JP2004501142A (ja) 2004-01-15
CA2411961A1 (en) 2001-12-27
SV2002000503A (es) 2002-07-03
YU93902A (sh) 2005-11-28
KR100525698B1 (ko) 2005-11-03
DE60104691T2 (de) 2005-01-13
DOP2001000190A (es) 2002-05-15
TR200401983T4 (tr) 2004-09-21
EP1292586B1 (en) 2004-08-04
WO2001098284A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
BR0213380A (pt) Derivados propiÈnicos alfa-oxissubstituìdos por beta-fenila: processo para sua preparação e seu uso na preparação de compostos farmaceuticamente importantes
BR9917518A (pt) Processos para a preparação de pestecidas 1-arilpirazóis e seus intermediários
BR0111581A (pt) Processos para a preparação de pirazolopirimidinonas
BR0215097A (pt) Processo para fazer o composto da fórmula e composto da fórmula
BR9810838A (pt) Processo para preparar derivados de 2-(3-pirazoliloximetileno)nitrobenzeno
BR9708233A (pt) Processo para sìntese de um composto e composto.
AR036000A1 (es) Proceso para la preparacion de derivados de indol y novedosos intermediarios
BR0110907A (pt) Preparação de compostos de ácido iminodiacético provenientes de substratos de monoetanolamina
BR9808854A (pt) Processo para preparação de um composto, e, composto
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR0103072A (pt) Processo para a preparação de compostos de pirazolo[4,3-d] pirimidin-7-ona e seus intermediários
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR0009453B1 (pt) processo para a preparação de um composto.
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BR0208967A (pt) Monoazocorantes fibrorreativos
BR9807154A (pt) Processo para a produção de um composto de 2,3-di-hidroxipropilaamino, e , composto.
BRPI0013751B8 (pt) processo para produção de derivados de ácido naftiridina-3-carboxílico.
BR0014727A (pt) Processo para preparar o ácido 7-amino-3-metóxi-metil-3-cefem-4-carboxìlico
BR0013799A (pt) Processo para a preparação de um composto, e, composto
BR0210512A (pt) Processo de decomposição papa o ácido (r)-(-)-2-hidroxi-2-(2-clorofenil) acético
BR0000184A (pt) Processo para a preparação de compostos heterocìclicos
BR0111864A (pt) Processo para a preparação de pirazolopirimidinonas
BR0113944A (pt) Processo para a produção de compostos quirais
PT1317455E (pt) Processo para a preparacao de um composto de imidazopiridina substituido
BR0108130A (pt) Processos para a produção e preparação de um composto, e, composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 8A, 9AE 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.